# Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus

> **NCT03219801** · EARLY_PHASE1 · UNKNOWN · sponsor: **Hebei Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** mesenchymal stem cells

## Key facts

- **NCT ID:** NCT03219801
- **Lead sponsor:** Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219801, "Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03219801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*